Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
Ciardiello F, Troiani T, Caputo F, De Laurentiis M, Tortora G, Palmieri G, De Vita F, Diadema MR, Orditura M, Colantuoni G, Gridelli C, Catalano G, De Placido S, Bianco AR. Ciardiello F, et al. Among authors: diadema mr. Br J Cancer. 2006 Jun 5;94(11):1604-9. doi: 10.1038/sj.bjc.6603141. Br J Cancer. 2006. PMID: 16685276 Free PMC article. Clinical Trial.
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S, Damiano V, Simeone E, Diadema MR, Lieto E, Castellano P, Pepe S, De Placido S, Galizia G, Di Martino N, Ciardiello F, Catalano G, Bianco AR. De Vita F, et al. Among authors: diadema mr. Br J Cancer. 2005 May 9;92(9):1644-9. doi: 10.1038/sj.bjc.6602573. Br J Cancer. 2005. PMID: 15856038 Free PMC article. Clinical Trial.
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
Iovino F, Ferraraccio F, Orditura M, Antoniol G, Morgillo F, Cascone T, Diadema MR, Aurilio G, Santabarbara G, Ruggiero R, Belli C, Irlandese E, Fasano M, Ciardiello F, Procaccini E, Lo Schiavo F, Catalano G, De Vita F. Iovino F, et al. Among authors: diadema mr. Cancer Invest. 2008 Apr-May;26(3):250-5. doi: 10.1080/07357900701560612. Cancer Invest. 2008. PMID: 18317965
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer.
Morgillo F, De Vita F, Antoniol G, Orditura M, Auriemma PP, Diadema MR, Lieto E, Savastano B, Festino L, Laterza MM, Fabozzi A, Ventriglia J, Petrillo A, Ciardiello F, Barbarisi A, Iovino F. Morgillo F, et al. Among authors: diadema mr. Curr Oncol. 2013 Aug;20(4):e283-8. doi: 10.3747/co.20.1380. Curr Oncol. 2013. PMID: 23904766 Free PMC article.
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis.
Orditura M, Galizia G, Diana A, Saccone C, Cobellis L, Ventriglia J, Iovino F, Romano C, Morgillo F, Mosca L, Diadema MR, Lieto E, Procaccini E, De Vita F, Ciardiello F. Orditura M, et al. Among authors: diadema mr. ESMO Open. 2016 Mar 7;1(2):e000038. doi: 10.1136/esmoopen-2016-000038. eCollection 2016. ESMO Open. 2016. PMID: 27843594 Free PMC article.
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
Bogina G, Lunardi G, Coati F, Zamboni G, Gori S, Bortesi L, Marconi M, Cassandrini PA, Turazza M, Cortesi L, DeMatteis E, Ficarra G, Ibrahim T, Serra P, Medri L, Giraudi S, Lambertini M, Carli F, Foglietta J, Sidoni A, Nunzi M, Ficorella C, Diadema MR, Del Mastro L. Bogina G, et al. Among authors: diadema mr. Tumori. 2015 Jul-Aug;101(4):398-403. doi: 10.5301/tj.5000323. Epub 2015 May 22. Tumori. 2015. PMID: 26045108
12 results